Dalton, Greiner, Hartman, Maher & Co’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-35,795
Closed -$1.02M 201
2015
Q3
$1.02M Sell
35,795
-461
-1% -$13.2K 0.06% 163
2015
Q2
$1.07M Buy
36,256
+669
+2% +$19.4K 0.06% 170
2015
Q1
$1.13M Sell
35,587
-834
-2% -$25.5K 0.06% 160
2014
Q4
$1.2M Sell
36,421
-37,709
-51% -$1.09M 0.07% 154
2014
Q3
$2M Sell
74,130
-20,552
-22% -$569K 0.11% 111
2014
Q2
$2.59M Sell
94,682
-44,959
-32% -$1.15M 0.14% 102
2014
Q1
$3.19M Buy
139,641
+43,596
+45% +$849K 0.19% 98
2013
Q4
$1.69M Buy
96,045
+43,375
+82% +$748K 0.1% 120
2013
Q3
$904K Buy
+52,670
New +$840K 0.06% 160

Other funds holding LDL

Dalton, Greiner, Hartman, Maher & Co's LDL Position: Q4 2015 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of Lydall, Inc. (LDL) in Q4 2015, closing a stake of 35,795 shares — an estimated $1.02M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in LDL in Q3 2013 and held it in 9 quarters. The position peaked at $3.19M in Q1 2014. 141 funds tracked by Wall St. Rank hold LDL as of Q4 2015.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining Lydall, Inc. position as of Q4 2015 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 35,795 Lydall, Inc. shares in Q4 2015, an estimated $1.02M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in Lydall, Inc. in Q3 2013 and held it in 9 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's Lydall, Inc. position peaked at $3.19M in Q1 2014.
  • 141 funds tracked by Wall St. Rank held Lydall, Inc. as of Q4 2015.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q4 2015, filed 14 Jan 2016.